Changing Market Dynamics of Shingles in the Seven Major Markets

April 14 21:40 2021
Changing Market Dynamics of Shingles in the Seven Major Markets

Shingles Market” report has been added to DelveInsight

 

The Shingles market report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM Shingles market.

 

Shingles Disease Overview

Shingles, also known as herpes zoster (HZ), is a viral infection caused by the chickenpox virus, varicella-zoster virus (VZV). Herpes zoster results from activation of the virus, which in many instances has remained latent for years following a primary chickenpox infection. Once active, the virus travels along a nerve to the skin and causes a rash.

 

Download free sample copy here- https://www.delveinsight.com/sample-request/shingles-market

 

Shingles Market: Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

 

Shingles Key Players

  • Novartis
  • GlaxoSmithKline
  • Maruho
  • GlaxoSmithKline
  • Nobelpharma
  • Curevo

 

Shingles Market Drugs

  • Famvir (famciclovir)
  • Valtrex (valacyclovir)
  • Amenalief (amenamevir)
  • Shingrix
  • Fostoin
  • CRV-101

 

Shingles Market Report

During chickenpox, the virus spreads in the bloodstream and infects collections of nerve cells (ganglia) of the spinal or cranial nerves. The virus remains in the ganglia in an inactive (dormant or latent) state. The virus may never cause symptoms again, or it may reactivate many years later. When it reactivates, the virus travels down the nerve fibers to the skin, where it creates painful sores resembling those of chickenpox. This outbreak of sores (shingles) almost always appears on a strip of the skin over the infected nerve fibers and only on one side of the body. This strip of skin, the area supplied by nerve fibers from a single spinal nerve region, is called a dermatome. Sores may also appear on the dermatomes or next to the affected dermatome.

 

Shingles Symptoms

Early symptoms of shingles may include fever and general weakness. During the 2 or 3 days before shingles development, most people have pain, a tingling sensation, or itching in a strip of skin (a dermatome) on one side of the body. Clusters of small, fluid-filled blisters surrounded by a small red area then develop on the strip of skin. Typically, the blisters occur only on the limited area of skin supplied by the infected nerve fibers. They are most common on the torso and face, but they can occur elsewhere as well. In rare cases, the rash appears on the lower body. Though, Shingles may develop at any age but is most common after age 50. The chance of developing shingles increases as people age.

 

Shingles Market Report Highlights

  • Shingles symptoms are usually less severe in children than in adults.
  • Postherpetic neuralgia (PHN) is the most common complication of herpes zoster. PHN is pain that persists in the area where the rash once was for more than 90 days after rash onset, which can last for weeks or months, and occasionally, for years. About 1 in 10 adults with herpes zoster develop PHN.

 

Shingles Market Insights

Treatment for Shingles must be initiated by a dermatologist or other health-care provider within 3 days of getting the rash. Ideally, if the treatment is initiated within 3 days, it can prevent possible complications, such as long-lasting nerve pain. However, receiving treatment after 3 days still has benefits.

 

Following is the TOC of Shingles market report

1. Key Insights

2. Executive Summary of Shingles

3. Competitive Intelligence Analysis for Shingles

4. Shingles: Market Overview at a Glance

5. Shingles: Disease Background and Overview

6. Patient Journey

7. Shingles Epidemiology and Patient Population

9. Unmet Needs

10. Key Endpoints of Shingles Treatment

11. Marketed Products

12. Emerging Therapies

13. Shingles: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Shingles

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this Shingles Market Report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Shingles market
  • To understand the future market competition in the Shingles market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Shingles in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Shingles market
  • To understand the future market competition in the Shingles market

 

View Latest Reports

Hepatocellular Carcinoma Epidemiology

DelveInsight’s Hepatocellular Carcinoma – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Hepatocellular Carcinoma in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Chronic Bronchitis Market

DelveInsight’s Chronic Bronchitis – Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

 

Contact Us

Shruti Thakur

[email protected]

USA: – +1(919)321-6187

India:- +91-11-45689769, +91-9650213330

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Vinita Rakheja
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: www.delveinsight.com/

  Categories: